Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer
Anne Sofie Brems-Eskildsen, Søren Linnet, Hella Danø, Adam Luczak, Peter Michael Vestlev, Erik Hugger Jakobsen, Jeppe Neimann, Charlotte Buch Jensen, Trine Dongsgaard, Sven Tyge Langkjer
Udforsk hvilke forskningsemner 'Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer' indeholder.